Advertisement

Topics

Exonics raises $40mm Series A round from The Column Group

14:40 EST 9 Nov 2017 | Elsevier Business Intelligence

Duchenne muscular dystrophy (DMD) gene therapy start-up Exonics Therapeutics Inc. raised a $40mm Series A round from The Colu...

Original Article: Exonics raises $40mm Series A round from The Column Group

NEXT ARTICLE

More From BioPortfolio on "Exonics raises $40mm Series A round from The Column Group"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Muscular Dystrophy
Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral mu...

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...